List of Synlogic patents

List of Synlogic patents

List of Radware patents

List of Ipsen patents

List of Lufkin Industries patents

List of oven patents

Companies in the Technology, Information and Internet industry

Patents where

Current Assignee

Name

is

Synlogic

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11439673 Bacteria engineered to treat liver disease		Synlogic	Synlogic		United States Patent and Trademark Office	11439673	September 13, 2022
	‌ US Patent 11273184 Bacteria engineered to treat disorders in which oxalate is detrimental	Patent 11273184 was granted and assigned to Synlogic on March, 2022 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	11273184	March 15, 2022
	‌ US Patent 11384359 Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier	Patent 11384359 was granted and assigned to Synlogic on July, 2022 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	11384359	July 12, 2022
	‌ US Patent 11291693 Bacteria engineered to treat metabolic diseases	Patent 11291693 was granted and assigned to Synlogic on April, 2022 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	11291693	April 5, 2022
	‌ US Patent 11471494 Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells	Patent 11471494 was granted and assigned to Synlogic on October, 2022 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	11471494	October 18, 2022
	‌ US Patent 10273489 Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier	Patent 10273489 was granted and assigned to Synlogic on April, 2019 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	10273489	April 30, 2019
	‌ US Patent 9487764 Bacteria engineered to treat diseases associated with hyperammonemia	Patent 9487764 was granted and assigned to Synlogic on November, 2016 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	9487764	November 8, 2016
	‌ US Patent 10933102 Bacteria engineered to treat a disease or disorder	Patent 10933102 was granted and assigned to Synlogic on March, 2021 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	10933102	March 2, 2021
	‌ US Patent 9688967 Bacteria engineered to treat diseases associated with hyperammonemia	Patent 9688967 was granted and assigned to Synlogic on June, 2017 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	9688967	June 27, 2017
	‌ US Patent 9889164 Bacteria engineered to treat a disease or disorder	Patent 9889164 was granted and assigned to Synlogic on February, 2018 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	9889164	February 13, 2018
	‌ US Patent 11618894 Bacteria engineered to reduce hyperphenylalaninemia	Patent 11618894 was granted and assigned to Synlogic on April, 2023 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	11618894	April 4, 2023
	‌ US Patent 9943555 Bacteria engineered to reduce hyperphenylalaninemia	Patent 9943555 was granted and assigned to Synlogic on April, 2018 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	9943555	April 17, 2018
	‌ US Patent 11060073 Bacteria engineered to treat diseases associated with hyperammonemia	Patent 11060073 was granted and assigned to Synlogic on July, 2021 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	11060073	July 13, 2021
	‌ US Patent 10195234 Bacteria engineered to reduce hyperphenylalaninemia	Patent 10195234 was granted and assigned to Synlogic on February, 2019 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	10195234	February 5, 2019
	‌ US Patent 10610546 Bacteria engineered to reduce hyperphenylalaninemia	Patent 10610546 was granted and assigned to Synlogic on April, 2020 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	10610546	April 7, 2020
	‌ US Patent 11766463 Microorganisms engineered to reduce hyperphenylalaninemia	Patent 11766463 was granted and assigned to Synlogic on September, 2023 by the United States Patent and Trademark Office.	Synlogic	Synlogic		United States Patent and Trademark Office	11766463	September 26, 2023
	‌ US Patent 11685925 Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier		Synlogic	Synlogic		United States Patent and Trademark Office	11685925	June 27, 2023

17 results

0 selected

17 results

0 selected